Press releases

Results to include nine-month data on TAXUS® Liberte™

Lawsuit alleges that the Conor CoStar™ Paclitaxel-Eluting Coronary Stent System infringes a balloon catheter patent owned by Boston Scientific

Court finds Sahajanand's Infinnium paclitaxel-eluting stent infringed two claims of an Angiotech patent

Endoscopic vessel harvesting speeds recovery and reduces pain and scarring; new products offer clinicians more choices to improve patient outcomes

A live webcast and replay of the May 4 conference session will be available

A live webcast and replay of the May 2 conference session will be available

Includes recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs)

Both were members of the board of directors of Guidant Corporation, which was acquired by the Company last week

Company elected to adjust the interest rates due to the closing of the Company's acquisition of Guidant Corporation

Creates a global leader in cardiovascular devices and one of the largest medical technology companies in the world

Transaction scheduled to close tomorrow

"We are very pleased that we achieved record company sales for the quarter," said Jim Tobin, President and Chief Executive Officer

New study seeks to define potential of Precision™ system to treat large population of U.S. migraine sufferers who don't respond adequately to current therapies

Company must also receive antitrust approval from the U.S. Federal Trade Commission (FTC) before it can close the Guidant transaction

A live webcast and replay of the April 18 conference call will be available

Agreement subject to approval by FTC Commissioners

Company's newest addition to its broad portfolio of vascular access products

At separate special meetings today, shareholders of each company have voted overwhelmingly to approve

Features a number of elements designed to enhance steering, handling and tracking during peripheral and coronary procedures

Diabetics and other complex patients see strong results with TAXUS stents

Company plans to appeal the judgment of the Delaware U.S. District Court

Details currently confidential; will become public when the European Commission announces its decision

ISS report notes the "compelling strategic rationale" for the combination of companies

Results of the study were published in today's edition of JAMA

Six-month results are consistent with ARRIVE I data